Bladder Cancer Update & Renal Cell Cancer Update, 2017 (Video Program)


Response to immune checkpoint inhibition, duration of therapy and immune-related adverse events in RCC
5:54 minutes.

BLADDER CANCER
(Neo)adjuvant treatment for urothelial bladder cancer (UBC)

Therapeutic options for patients with advanced UBC

Immune checkpoint blockade in UBC

RENAL CELL CANCER
Adjuvant sorafenib or sunitinib for renal cell carcinoma (RCC)

Selection and sequencing of therapeutic options for advanced RCC

Immune checkpoint blockade in RCC